Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Soraya Berjaya Indonesia Tbk. (SPRE) Price & Performance

Brigit Biofarmaka Teknologi Tbk.Trade
Soraya Berjaya Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Brigit Biofarmaka Teknologi Tbk. vs Soraya Berjaya Indonesia Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume), while Soraya Berjaya Indonesia Tbk. trades at Rp86 (market cap 71.2B, 362.9K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 2.3× Soraya Berjaya Indonesia Tbk.'s market cap, and Soraya Berjaya Indonesia Tbk. is more actively traded (362.9K versus 187.4K). Which is the better fit depends on your goals.

OBATSPRE
Market Cap
164.65B71.2B
Volume
187.4K362.9K
Lot
1.87K3.63K
Turnover
44.35M31.27M
Average Price
236.6786.16
Value
44.35M31.27M
Indicative Equilibrium Price
24286
Indicative Equilibrium Volume
500324

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

OBAT
View details
SPRE
View details

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT

About Soraya Berjaya Indonesia Tbk.

PT. Soraya Berjaya Indonesia (Company) was established based on Deed No. 05 dated March 05, 2015 by Notary Martalena, S.H., in Padang. Perseroan memulai kegiatan komersilnya pada tahun 2015. dengan mengoperasikan menggunakan merek dagang Soraya Bed Sheet.

Read more on SPRE